Erratum: Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads (Bone Marrow Transplantation (2015) 50 (1358-1364) DOI: 10.1038/bmt.2015.135);Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads

Bone Marrow Transplantation

Volumn 50, Issue 10, 2015, Pages 1358-1364

  Verfuerth, S ^a   Sousa, P S E ^a   Beloki, L ^b   Murray, M ^a   Peters, M D ^a   Mackinnon, S ^c   Lowdell, M W ^a,c   Chakraverty, R ^a   Samuel, E R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Atención Primaria Y Promoción de La Salud   (Spain)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CD45RA ANTIGEN; GAMMA INTERFERON; L SELECTIN; MAGNETIC BEAD; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEASIBILITY STUDY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMORY T LYMPHOCYTE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; NORMAL HUMAN; PROCEDURES;

ADOPTIVE TRANSFER; CD8-POSITIVE T-LYMPHOCYTES; HEALTHY VOLUNTEERS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOMAGNETIC SEPARATION;

EID: 84943448752     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2016.30     Document Type: Erratum

References (25)

1. Montagna D, Yvon E, Calcaterra V, Comoli P, Locatelli F, Maccario R, et al. Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia, and antiviral activity. Blood 1999; 93: 3550-3557
2. Samarasinghe S, Mancao C, Pule M, Nawroly N, Karlsson H, Brewin J, et al. Functional characterization of alloreactive T cells identifies CD25, and CD71 as optimal targets for a clinically applicable allodepletion strategy. Blood 2010; 115: 396-407
3. Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ, et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 2003; 112: 101-108
4. Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ. Transfer of allogeneic CD62Lmemory T cells without graft-versus-host disease. Blood 2004; 103: 1534-1541
5. Juchem KW, Anderson BE, Zhang C, McNiff JM, Demetris AJ, Farber DL, et al. A repertoire-independent, and cell-intrinsic defect in murine GVHD induction by effector memory T cells. Blood 2011; 118: 6209-6219
6. Foster AE, Marangolo M, Sartor MM, Alexander SI, Hu M, Bradstock KF, et al. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naïve T cells: potential for adoptive immunotherapy, and allodepletion. Blood 2004; 104: 2403-2409
7. Teschner D, Distler E, Wehler D, Frey M, Marandiuc D, Langeveld K, et al. Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis. Bone Marrow Transplant 2014; 49: 138-144
8. Bleakley M, Heimfeld S, Jones LA, Turtle C, Krause D, Riddell SR, et al. Engineering human peripheral blood stem cell grafts that are depleted of naive T cells, and retain functional pathogen-specific memory T cells. Biol Blood Marrow Transplant 2014; 20: 705-716
9. Davies JK, Koh MB, Lowdell MW. Antiviral immunity, and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical, and HLA-mismatched settings. Biol Blood Marrow Transplant 2004; 10: 259-268
10. Peggs KS, Verfuerth S, Pizzey A, Khan N, Guiver M, Moss PA, et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 2003; 362: 1375-1377
11. Distler E, Bloetz A, Albrecht J, Asdufan S, Hohberger A, Frey M, et al. Alloreactive, and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells. Haematologica 2011; 96: 1024-1032
12. Peggs KS, Thomson K, Hart DP, Geary J, Morris EC, Yong K, et al. Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood 2004; 103: 1548-1556
13. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, et al. Phenotypic, and functional separation of memory, and effector human CD8+T cells. J Exp Med 1997; 186: 1407-1418
14. Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype, and function of human T lymphocyte subsets: consensus, and issues. Cytometry A 2008; 73: 975-983
15. Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest 2008; 118: 294-305
16. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011; 17: 1290-1297
17. Kaneko S, Mastaglio S, Bondanza A, Ponzoni M, Sanvito F, Aldrighetti L, et al. IL-7, and IL-15 allow the generation of suicide gene-modified alloreactive selfrenewing central memory human T lymphocytes. Blood 2009; 113: 1006-1015
18. Verdijk RM, Kloosterman A, Pool J, van de Keur M, Naipal AM, van Halteren AG, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation, and immunotherapy. Blood 2004; 103: 1961-1964
19. Amir AL, D'Orsogna LJ, Roelen DL, van Loenen MM, Hagedoorn RS, de Boer R, et al. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010; 115: 3146-3157
20. Lundqvist A, Smith AL, Takahashi Y, Wong S, Bahceci E, Cook L, et al. Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF. J Immunol 2013; 191: 6241-6249
21. De Boer F, Dräger AM, Van der Wall E, Pinedo HM, Schuurhuis GJ. Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants. Bone Marrow Transplant 1998; 22: 1103-1110
22. Distler E, Wolfel C, Kohler S, Nonn M, Kaus N, Schnurer E, et al. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice. Exp Hematol 2008; 36: 451-463
23. Albrecht J, Frey M, Teschner D, Carbol A, Theobald M, Herr W, et al. IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential, and early differentiation phenotype. Cancer Immunol Immunother 2011; 60: 235-248
24. Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T, et al. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 2010; 115: 4923-4933
25. Jedema I, van de Meent M, Pots J, Kester MG, van der Beek MT, Falkenburg JH. Successful generation of primary virus-specific, and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells, and regulatory T cells. Haematologica 2011; 96: 1204-1212